Tax withholding trims BridgeBio Oncology (BBOT) CEO Beltran’s share count
Rhea-AI Filing Summary
BridgeBio Oncology Therapeutics, Inc. reported that President and CEO Pedro Beltran had 1,047 shares of Common Stock withheld by the company at $7.80 per share to cover tax obligations from vesting restricted stock units. After this withholding, he directly holds 44,576 shares of Common Stock. This was a tax-withholding disposition, not an open-market sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Beltran Pedro
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,047 | $7.80 | $8K |
Holdings After Transaction:
Common Stock — 44,576 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares withheld for taxes: 1,047 shares
Withholding price: $7.80 per share
Shares held after transaction: 44,576 shares
3 metrics
Shares withheld for taxes
1,047 shares
Common Stock withheld to satisfy tax obligations on RSU vesting
Withholding price
$7.80 per share
Value per share for tax-withholding disposition
Shares held after transaction
44,576 shares
Direct Common Stock holdings of CEO Pedro Beltran after withholding
Key Terms
restricted stock units, tax withholding obligations, Common Stock, tax-withholding disposition
4 terms
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations"
Common Stock financial
"shares of the Issuer's Common Stock withheld by the Issuer"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did BridgeBio Oncology (BBOT) report for its CEO?
BridgeBio Oncology reported a tax-related share withholding for its CEO. The company withheld 1,047 shares of Common Stock to cover Pedro Beltran’s tax obligations arising from vesting restricted stock units, rather than an open-market purchase or sale.
What are Pedro Beltran’s BridgeBio Oncology (BBOT) holdings after this transaction?
Following the tax-withholding transaction, Pedro Beltran directly holds 44,576 shares of BridgeBio Oncology Common Stock. This figure reflects his position after the company withheld 1,047 shares to satisfy tax obligations from restricted stock unit vesting.
What does transaction code F mean in the BridgeBio Oncology (BBOT) Form 4?
Transaction code F indicates a tax-withholding disposition. In this case, BridgeBio Oncology withheld 1,047 shares of Common Stock from CEO Pedro Beltran to cover tax liabilities associated with the vesting of his restricted stock units, rather than a discretionary trade.